These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36722476)

  • 1. Micro-fragmented Fat Inhibits the Progression of Human Mesothelioma Xenografts in Mice.
    La Monica S; Coccé V; Bonelli M; Alessandri G; Alfieri R; Lagrasta CA; Frati C; Flammini L; Gianni A; Petrella F; Paino F; Pessina A
    Curr Cancer Drug Targets; 2023; 23(8):663-668. PubMed ID: 36722476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells.
    Coccè V; La Monica S; Bonelli M; Alessandri G; Alfieri R; Lagrasta CA; Madeddu D; Frati C; Flammini L; Lisini D; Marcianti A; Parati E; Paino F; Giannì A; Farronato G; Falco A; Spaggiari L; Petrella F; Pessina A
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma.
    Coccè V; Bonelli M; La Monica S; Alfieri R; Doneda L; Martegani E; Alessandri G; Lagrasta CA; Giannì A; Sordi V; Petrella F; Roncoroni L; Paino F; Pessina A
    Biochem Pharmacol; 2023 Aug; 214():115678. PubMed ID: 37399948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
    Chu NQ; Liu R; Colby A; de Forcrand C; Padera RF; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2020 Sep; 160(3):e159-e168. PubMed ID: 32044093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells.
    Petrella F; Coccè V; Masia C; Milani M; Salè EO; Alessandri G; Parati E; Sisto F; Pentimalli F; Brini AT; Pessina A; Spaggiari L
    Biomed Pharmacother; 2017 Mar; 87():755-758. PubMed ID: 28153512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.
    Nishikawa S; Tanaka A; Matsuda A; Oida K; Jang H; Jung K; Amagai Y; Ahn G; Okamoto N; Ishizaka S; Matsuda H
    Cancer Med; 2014 Apr; 3(2):416-25. PubMed ID: 24510578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
    Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
    Kaku Y; Nagaya H; Tsuchiya A; Kanno T; Gotoh A; Tanaka A; Shimizu T; Nakao S; Tabata C; Nakano T; Nishizaki T
    Cancer Sci; 2014 Jul; 105(7):883-9. PubMed ID: 24754309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.
    Zhang J; Khanna S; Jiang Q; Alewine C; Miettinen M; Pastan I; Hassan R
    Clin Cancer Res; 2017 Mar; 23(6):1564-1574. PubMed ID: 27635089
    [No Abstract]   [Full Text] [Related]  

  • 12. Downregulation of thymidylate synthase by RNAi molecules enhances the antitumor effect of pemetrexed in an orthotopic malignant mesothelioma xenograft mouse model.
    Abu Lila AS; Kato C; Fukushima M; Huang CL; Wada H; Ishida T
    Int J Oncol; 2016 Apr; 48(4):1399-407. PubMed ID: 26847426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam and cisplatin in a mouse model of peritoneal mesothelioma.
    Spugnini EP; Cardillo I; Verdina A; Crispi S; Saviozzi S; Calogero R; Nebbioso A; Altucci L; Cortese G; Galati R; Chien J; Shridhar V; Vincenzi B; Citro G; Cognetti F; Sacchi A; Baldi A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6133-43. PubMed ID: 17062690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
    Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
    J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxol inhibits growth of mesothelioma xenografts.
    Lee JM; Bruckner HW; Szrajer L; Brenne U; Schindelheim G; Andreotti PE
    Anticancer Res; 1995; 15(3):693-6. PubMed ID: 7645945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer agent α-sulfoquinovosyl-acylpropanediol enhances the radiosensitivity of human malignant mesothelioma in nude mouse models.
    Inamasu E; Tsuchiya T; Yamauchi M; Nishi K; Matsuda K; Sugawara F; Sakaguchi K; Mori R; Matsumoto K; Miyazaki T; Hatachi G; Doi R; Watanabe H; Tomoshige K; Matsuda N; Higami Y; Shimokawa I; Nakashima M; Nagayasu T
    J Radiat Res; 2022 Jan; 63(1):19-29. PubMed ID: 34738103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded expansile nanoparticles enhance chemotherapeutic drug delivery in mesothelioma 3-dimensional multicellular spheroids.
    Lei H; Hofferberth SC; Liu R; Colby A; Tevis KM; Catalano P; Grinstaff MW; Colson YL
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1417-24; discussion 1424-25.e1. PubMed ID: 25841659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells.
    He X; Wang L; Riedel H; Wang K; Yang Y; Dinu CZ; Rojanasakul Y
    Mol Cancer; 2017 Mar; 16(1):63. PubMed ID: 28288645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
    Li Q; Yano S; Ogino H; Wang W; Uehara H; Nishioka Y; Sone S
    Clin Cancer Res; 2007 Oct; 13(19):5918-25. PubMed ID: 17908988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.